New patent for MC2 drug WYNZORA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for WYNZORA
Annual Drug Patent Expirations for WYNZORA

Wynzora is a drug marketed by MC2 and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

This drug has eighteen patent family members in fourteen countries.

The generic ingredient in WYNZORA is betamethasone dipropionate; calcipotriene. One supplier is listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top